• Hydrostatic pressure is the Starling force driving filtration of fluid from the capillaries and is accessible to therapeutic manipulation; microcirculatory optimization means avoiding capillary hypertension and keeping capillary pressure as low as compatible with adequate tissue blood flow.
• Sigma delta Π, the effective colloid osmotic pressure difference across the endothelial glycocalyx, is the force opposing transendothelial filtration J v , but it does not in steady state reverse the flow to reabsorption. This new insight explains why biophysical colloid therapy is much less effective against oedema than has previously been taught.
As the evidence base is limited, we must take a rational approach to fluid therapy, but reason has to be based on familiarity with state-of-the-art physiological science. For about a decade, now it has been clear that most capillaries do not reabsorb filtered fluid, with the corollary that interstitial fluid is in a vital steadystate circulation at about 5-10 ml min −1 , and capillary filtration rate can increase to 100 ml min −1 or more with rapid 1 litre fluid bolus. Applying a paradigm that views extracellular fluid (ECF) as two linked circulations rather than two relatively static compartments changes our deductions as to what constitutes rational fluid therapy, and explains many if not all of the otherwise inexplicable clinical and experimental findings. Colloid therapy to support plasma volume has been promoted by international experts and the pharmaceutical industry since Bayliss and Starling recommended gum saline for the treatment of wound shock in 1916, and so this kinetic paradigm based on the steady-state Starling principle may not be readily accepted in some quarters.
A kinetic approach to the circulation of ECF
Enteral fluid absorbed by the intestinal mucosal capillaries and parenteral fluid infused into a vein enter a central volume of distribution. The capillary filtration rate (or the transendothelial flow of solvent J v ) is a primary determinant of the redistribution of fluid from the central to the peripheral volume of distribution ( Fig. 1) . Clinicians intending to manipulate the ECF to achieve optimal plasma volume without causing tissue oedema must therefore understand the Starling forces which determine J v . They are traditionally represented in mathematical form as the Starling equation with two driving forces, capillary pressure (P c ) and interstitial protein osmotic pressure (Π i ). The two opposing forces are plasma protein osmotic pressure (Π p ) and interstitial pressure (P i ). Charles Michel and Sheldon Weinbaum are jointly credited with a new interpretation of the Starling equation which recognizes that the protein osmotic pressure difference (delta Π) opposing filtration is developed across the luminal endothelial glycocalyx layer, making Π i a misleading irrelevance.
As the subglycocalyx space is almost protein-free during filtration (subglycocalyx protein osmotic pressure Π g is close to zero), P c is essentially the only driving force. 1 This seemingly minor change has some major consequences for our understanding of ECF kinetics.
(i) The diagram, represented in every physiology textbook, of fluid being filtered to the interstitium at the beginning of blood's transit through a capillary, and then reabsorbed as it approaches the venules, is incorrect. (ii) Staverman's reflection coefficient sigma, which modifies the measured delta Π to the effective delta Π in the Starling equation, is a characteristic of the glycocalyx layer and its interaction with albumin. (iii) At steady state, the hydrostatic pressure difference (delta P) driving filtration is always larger than sigma delta Π and so capillaries produce filtrate along their entire length. The traditional teaching of filtration being balanced by reabsorption as the dominance of hydrostatic and colloid osmotic pressure differences shifts does not occur. This is the steady-state no-reabsorption rule. (iv) The traditional view of lymph flow being compensation for a slight net positive filtration-reabsorption balance is obsolete. Sigma delta Π opposing filtration is much greater, and so J v is much less than previously believed, and the ultrafiltrate is almost all returned to the blood circulation as the volume flow of lymph Q lymph .
Practice point
The steady-state no absorption rule explains why biophysical infusion therapy to raise the plasma oncotic pressure will have much less effect on plasma volume and on tissue oedema than the traditional filtration-absorption balance interpretation of the Starling forces had led us to expect.
The Starling equation
In narrative form, the transendothelial volume flow of solvent is proportionate to the net filtration pressure (hydrostatic pressure difference minus the effective oncotic pressure difference across the glycocalyx layer). The constant is the filtration coefficient, or alternatively is the hydraulic conductivity L p multiplied by the surface area for filtration A.
J v ¼ L p Aðdelta P À sigma delta ΠÞ I think anaesthetists are more familiar with the concept of resistance than conductance, so I suggest we could substitute transendothelial resistance (R te ) into Starling's equation:
New insights
The presence of an intravascular gel phase, the glycocalyx layer, separating free-flowing plasma from the junction breaks within intercellular cleft has clinical consequences. Attempts have been made to estimate the intravascular volume of the glycocalyx layer by indicator dilution, but Michel and Curry 2 have pointed out the methodological difficulties in obtaining a meaningful value. For the purposes of a paradigm that explains clinical experience, I have suggested that a bolus of an isosmotic plasma substitute has a central volume of distribution which approximates the free-flowing plasma, while a bolus of an isotonic salt solution has a central volume of distribution that includes the intravascular gel phase and approximates the whole of the intravascular volume. The concept is supported by consistent clinical reports that adequate resuscitation with an isosmotic plasma substitute can be achieved with slightly smaller volumes than adequate resuscitation with a crystalloid, but at the expense of much diluted haematocrit. 3 The ability of plasma and plasma substitutes to cause anaemia is still widely misinterpreted as indicating that the colloids are 'better volume expanders'. It has been traditional to think of intravascular volume as a measurable mass of fluid within a bucket to which one can add a colloid solution, and from which a colloid-free solution rapidly redistributes. In reality, the bucket wall has a spongy inner lining (the glycocalyx) and ranges from almost impermeable (the bloodbrain barrier) to cell filter function only (liver, spleen, and bone marrow), and the proportion of these contributions is not fixed, depending on cardiac output and regional blood flows. See the section 'Special microcirculations'. Attempting to attribute a more precise anatomic boundary to our conceptual compartments of what is really a kinetic fluid distribution equilibrium of the ECF in life is hopeless.
The distribution of ECF between intravascular and extravascular compartments
In health, indicator dilution studies give a 70 kg adult about 3 litre of plasma which contains around 210 g protein (70 g litre −1 ). The capillary pressure is greater than in the interstitial, causing solvent with its small lipophobic solutes to flow to the interstitial space via infrequent breaks in the junction strand which fuses adjacent endothelial cells together (Fig. 2) . In health, these junctional strand breaks are <10% of the endothelial cell perimeters and <0.1% of the total endothelial surface area. The solvent that has been filtered by the endothelial glycocalyx layer, so that it is almost protein-free as it enters the subglycocalyx protected space, is then jetted at a very high velocity through the junctional strand breaks. Consequently, there exist microdomains of very low protein interstitial fluid at the intercellular cleft exits. Beyond these cleft exit microdomains, the 70 kg adult has about 12 litre interstitial fluid in a gel phase which contains 240-360 g protein (20-30 g litre −1 ).
Traditional pore theories presumed the existence of small (Stokes radius <2 nm) and large (Stokes radius >3 nm) cylindrical pores through the capillary barrier. The Stokes radius of albumin is about 3 nm, and the hypothetical large pores allowed albumin to move through them in either direction. Mathematical analysis of physiological measurements and electron microscopic studies now point to linear discontinuities (breaks) in the interendothelial junctional strand rather than cylindrical pores being the major route of transendothelial fluid flux J v , the overlying glycocalyx layer being the major filter. The length and number of junctional strand breaks and the condition of the adherens junction proteins contribute to the resistance to filtration. The asymmetric anatomy causes paracellular fluid flux to be a one-way street. The ability of capillaries to filter only 5.5 ml min −1 J v from the 3 litre of plasma that pass through each of the pulmonary and systemic microcirculations per minute is a remarkable feat of autoregulation. If, in an experiment on healthy adult human subjects, capillary pressure is acutely elevated by bolusing a litre of isotonic saline i.v. in <10 min, haematocrit dilution studies suggest that J v increases transiently to around 100 ml min
. In laboratory studies, acute reduction in capillary pressure to less than sigma delta Π upsets the steady state and results in an immediate reversal of capillary filtration to reabsorption, but this physiological autotransfusion is transient (<30 min) and limited (<500 ml in the 70 kg adult) before a new steady-state condition of reduced filtration is re-established. As interstitial fluid flows back up the interendothelial cleft and enters the subglycocalyx protected space, it carries with it proteins which cannot pass through the glycocalyx layer, so that delta π across the glycocalyx is rapidly diminished until absorption ceases (Fig. 2) . This mechanism has been called the glycocalyx model or the Michel-Weinbaum model.
Practice point
Small reductions in the regional vascular resistance of a tissue bed below normal lead to substantial increases in P c and J v . Precapillary vasodilators cause oedema as a side-effect. α-1 adrenergic agonists help keep P c low by precapillary arteriolar constriction. They minimize delta P and therefore J v and so are an effective anti-oedema therapy. Examples include epinephrine treatment of anaphylaxis/ anaphylactoid reactions and anti-hypotensive infusions of norepinephrine or phenylephrine in anaesthetic practice.
There is an exception to the no-absorption rule when there is an independent supply of fluid to the interstitium disturbing the steady state, such as intestinal absorption, endocrine secretion, and renal peritubular absorption. Consider also subcutaneous or i.m. injections of isotonic saline and water-soluble drugs which are rapidly absorbed. The explanation is that the proteinfree exogenous fluid can be absorbed by adjacent capillaries until the protein-free reservoir has been removed and tissue proteins start to increase into the subglycocalyx protected zone. Absorption then ceases, and steady-state filtration is re-established.
In organs with high tissue to blood solute exchange rates, non-sinusoidal endothelial cells (continuous capillaries) can develop cartwheel-shaped diaphragm fenestrations, where the luminal and abluminal membranes of the endothelial cell are in close proximity. Examples include renal peritubular capillaries and intestinal mucosal capillaries. Under the inflammatory influence of vascular endothelial growth factor, fenestrations can appear in normally non-fenestrated capillaries.
The paracellular ultrafiltrate accounts for most of the baseline 8 litre day −1 . In steady-state conditions, afferent lymphatic fluid is also formed at the rate of about 8 litre day −1 and has the same protein concentration as the interstitial fluid (20-30 g litre −1 ) . Diaphragm-fenestrated blood capillaries within lymph nodes are able to absorb lymphatic fluid and return it to the circulation at the rate of about 4 litre day −1 , leaving around 4 litre day −1 of proteinaceous (circa 60 g litre −1 ) efferent lymph to return to the venous system via the thoracic duct. Lymph flow is not entirely passive. There is smooth muscle associated with many lymphatics whose contraction and relaxation acts as a pump.
While inflammatory mediators and opioids may inhibit lymphatic contractility, so promoting oedema, norepinephrine is known to stimulate contractility.
Only about 8 litre of the interstitial fluid is within an anatomic space that allows contraction or expansion, so in kinetic terms, the peripheral distribution volume of infused isotonic saline is substantially less than the total interstitial fluid volume.
Inflammation; more than just leaky capillaries
One of the first consequences of inflammation is a decrease in the interstitial pressure P i as integrins change the conformation and hydration of structural collagen fibres. Delta P and J v therefore increase, beginning the shift of ECF balance from the intravascular to the extravascular compartment. Precapillary vasodilation increases the capillary pressure P c and so further increases J v . If the haemodynamic reflexes are working, arterial pressure is maintained by increased cardiac output (capillary recruitment increasing the surface area for filtration A), which is another factor increasing J v in the early phase of systemic inflammation. Notice that I have accounted for a substantial increase in J v to the interstitium and so far have not had to appeal to the 'leakiness' of the capillary expressed as the hydraulic conductivity L p or Staverman's reflection coefficient sigma. Histamine and other autocoids are known to increase the length and number of intercellular junction breaks, especially in the distal part of the capillary and the venules. The surface area for filtration within each capillary and the hydraulic conductivity L p are both thereby increased and further increase the J v . Fragmentation of the glycocalyx, and failure of the repair mechanisms eventually reduce sigma so that the effective delta Π (sigma delta Π) opposing filtration is reduced.
The circulation of proteins
Proteins such as albumin are transported from the intravascular to extravascular space by two pathways: first, as the glycocalyx is an imperfect filter (reflection coefficient sigma for albumin <1.0) some albumin passes through intercellular clefts ('paracellular pathway') as part of the convection current, and second via a diffusive caveolation from the luminal to the abluminal side of the endothelial cell ('transcellular pathway'). Expressed as a mathematical formula, the mass flow of a solute such as albumin (J s albumin) is the sum of the convective and the diffusive components. J s can be measured as the transcapillary escape rate (TCER) of a radio-labelled marker. Using I 131 , TCER albumin is about 5% h −1 , or about 10 g h −1 when the plasma albumin concentration is normal. In health, while J v is low, transcellular pathway for J s predominates. However, when paracellular hyperfiltration occurs, this pathway for J s predominates. TCER albumin increases by up to 300% (i.e. to 15% h −1 ) in surgical patients, in cancer patients, and in sepsis.
Practice point
Even in health, there is at any moment more extracellular albumin within the interstitial fluid than in the plasma. During hyperfiltration and hyperpermeability, plasma albumin concentration decreases because of net redistribution of circulating albumin to the interstitial space. Transfused albumin is also rapidly redistributed so that there is soon more of it in the tissues than in the plasma volume. Excessive transfusion of albumin will overload the interstitium and cause oedema, every gram of albumin holding about 18 ml water in the interstitial gel.
Resuscitation from low intravascular volume and low capillary pressure
As J v is close to zero at low capillary pressures, plasma volume expansion from hypovolaemia can be achieved with an isotonic salt solution, an isosmotic albumin solution, or a plasma substitute. Only when P c (or more accurately delta P) has been restored to the point at which the convection jet of ultrafiltrate emerging from each junction strand break has maximized the opposing sigma delta Π will further fluid loading lead to a proportionate increase in J v . I have described this flow-pressure relationship as a J curve and suggested that the inflection point be called the J point. 3 
The more severe the hypovolaemia, the greater the case for preferring crystalloid resuscitation to repay the autotransfusion and reestablish a subglycocalyx protected space. This logic runs counter to the suggestion by some authorities that colloid solutions may be preferred in more extreme cases of hypovolaemia 'because it stays in the circulation longer'. Moreover, statim boluses will cause transient peaks of P c that lead to transient hyperfiltration. This may account for the finding of the FEAST trial that large bolus resuscitation was harmful. 4 Randomized trials are needed to inform us of the best approach, but small boluses of non-colloid isotonic salt solutions repeated after frequent reassessment look preferable to larger boluses given at 100 ml min −1 or more.
Tonic regulation of capillary permeability
The in vivo capillary filtration unit needs almost continuous maintenance and tonic regulation of its permeability. 5 The key regulating parts of the capillary filtration unit are the adherens junctions, the continuity of the tight junctional strands (length and number of breaks), and the balance of synthesis and degradation of glycocalyx layer components. The small GTP-ase enzymes which maintain the near-impermeability of the capillary filtration unit require a continuous supply of intracellular cyclic adenosine monophosphate and a continuous supply of sphyngosine-1-phosphate (S1P), generated within circulating erythrocytes and carried to the endothelium by plasma albumin. Inflammation reduces activation of the small GTP-ases and so reduces the near-impermeability of the capillary filtration unit.
Practice point
Albumin is a glycocalyx component and a carrier of S1P and is necessary for the integrity of the endothelial barrier, but laboratory experiments suggest a plasma concentration as low as 10 g litre 
Plasma volume regulation by natriuretic peptides
An important endocrine regulator of plasma volume is atrial natriuretic peptide (ANP) whose actions are essentially the reverse of aldosterone. 7 ANP is secreted in response to vascular distension and acts on intra-renal and extra-renal guanylate cyclase (GC-A) receptors to reduce the effective plasma volume by at least three important actions. Intra-renal GC-A receptor stimulation brings about natriuresis by increasing glomerular filtration pressure (the efferent arterioles constrict) and inhibiting tubular sodium reabsorption. Secondly, extra-renal GC-A receptor stimulation increases the TCER of albumin (J s ), so that the delta Π opposing J v is not increased by the loss of salt and water from the circulation. Thirdly, GC-A receptors generally relax vascular smooth muscle.
Special microcirculations
The continuous endothelial cells of the pulmonary capillaries are exposed to the whole right ventricular output, but perfused by much lower arterial pressure. Traditionally, it is taught that pulmonary capillary wedge pressure >18 mm Hg leads to pulmonary oedema. It has been observed that increase in P c activates a heparan sulphate-nitric oxide-dependent pathway that fragments the glycocalyx layer and reduces transendothelial resistance, so accelerating the increase in J v which causes oedema formation. 8 In other words, hydrostatic pulmonary oedema is soon followed by permeability oedema and is not always rapidly reversed by reducing P c . Keeping the lymphatic drainage pressure (central venous pressure) low is likely to be of benefit. Glomerular filtration is a remarkable special case, by which around 120 ml min −1 ultrafiltrate leaves the plasma via glomerular open fenestrated capillaries to enter the renal tubule system. Glomerular glycocalyx injury leads to albuminuria. Peritubular diaphragm-fenestrated capillaries participate in secretion and reabsorption of solutes, while vasopressin/ antidiuretic hormone modifies the final reabsorption of water from the distal parts of the nephron to regulate ECF osmolality. Sinusoidal capillaries of the bone marrow, spleen, and liver have discontinuous basement membranes and glycocalyx layers, so that they do not filter proteins, and there is no delta Π opposing J v . Hepatocytes are therefore able to regulate Π p by regulating protein synthesis according to Π i in the Space of Diss. Intra-osseous fluid infusion is as effective as i.v. Around one-fifth of the left ventricular output passes through the hepatic microcirculation, and the liver contributes more to the lymphatic circulation than any other organ. In stabilized sepsis, as much as 50% of the left ventricular output perfuses the liver.
The capillaries of the central nervous system have fully continuous basement membrane and glycocalyx layer, with several lines of tight junction in every interendothelial cleft forming a very impermeable blood-brain barrier. Cleft exit microdomains appear to be associated with closely placed pericytes. Anatomically, there are no lymphatic vessels draining the interstitial fluid of the central nervous system, but a lymph-like flow of interstitial fluid around glial cells has been reported and is referred to as the glymph system. Anaesthesia and sleep are associated with increased glymph flow, which is speculated to wash potentially neurotoxic metabolites away. 9 
Conclusion
The Michel-Weinbaum steady-state Starling principle has important consequences for clinical practice. The hope that biophysical intravascular colloid therapy with albumin or plasma substitutes can deliver plasma volume support without causing oedema is in vain. The rational approach is to use isotonic salt solutions to support the ECF volume, while care is taken to avoid harmful capillary hypertension. In current practice, a judicious infusion of norepinephrine or phenylephrine is widely used to limit J v when fluids alone are not enough. Future therapies may be aimed at stabilizing the endothelial barrier.
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